Mechanistically, ANXA1 promotes the binding of USP5 to GOT1, thus preventing the degradation of GOT1 via the ubiquitin-proteasome pathway and promoting glutamine metabolism to enhance the oxidative stress adaptation of tumor cells and promote tumor growth. This evidence concerns the gene GOT1 and neoplasm.